H. influenzae vaccine for infants.
D001425:Bacterial Outer Membrane Proteins / Q000008:administration & dosage* / Q000009:adverse effects; D001426:Bacterial Proteins / Q000008:administration & dosage* / Q000009:adverse effects; D001428:Bacterial Vaccines / Q000008:administration & dosage* / Q000009:adverse effects; D004311:Double-Blind Method; D006192:Haemophilus Infections / Q000517:prevention & control*; D018073:Haemophilus Vaccines; D006193:Haemophilus influenzae; D006801:Humans; D007115:Immunization Schedule; D007223:Infant; D011135:Polysaccharides, Bacterial / Q000008:administration & dosage* / Q000009:adverse effects; D014614:Vaccines, Synthetic / Q000008:administration & dosage* / Q000009:adverse effects
D001425:Bacterial Outer Membrane Proteins; D001426:Bacterial Proteins; D001428:Bacterial Vaccines; D018073:Haemophilus Vaccines; C061964:Haemophilus influenzae-type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine; D011135:Polysaccharides, Bacterial; D014614:Vaccines, Synthetic; C061963:HibTITER protein, Haemophilus influenzae